Debridement Articles & Analysis
22 articles found
Nanotechnology has not only received attention and applications in the field of drug delivery, but also has achieved many successes in the field of tissue engineering. Nano dressings can be defined as dressings in which nanomaterials are the matrix. The birth of nano dressings has brought new treatment methods for wound repair and burn care, such as nanohydrogels, nanofibers, nanomembranes, ...
Garwood Medical Devices, LLC has been selected as an awardee of the Innovations for Vets Quickfire Challenge launched by Johnson & Johnson Innovation – JLABS with the Johnson & Johnson Office of Military and Veterans Affairs. The intention behind this challenge was to help advance innovation that could benefit the military community. As a company named after veterans, Garwood ...
Healing rate: 67.9 mm2/day. Healing time: 159 days. Wound size: 135 × 80 × 10 mm w/70-mm undermining at 3 o’clock. Age of wound when treatment started: 4 months. Subject: 44/male. Paraplegic. Frail with contractures and muscle wasting; tube fed, incontinent, dependent for all ...
Healing rate: 25.3 mm2/day. Healing time: 33 days. Wound size: 38 × 22 × 8 mm. Age of wound when treatment started: > 1 year. Subject: 52/male. Insulin dependent diabetic, peripheral neuropathy, hypertension, renal failure on hemodialysis; history of chronic foot ...
Healing rate: 14.3 mm2/day. Healing time: 103 days. Wound size: 49 × 30 × 3 mm. Age of wound when treatment started: ~ 3 months. Subject: 62/male. Non-insulin dependent diabetes, venous insufficiency, peripheral neuropathy, HTN, CHF, COPD, ...
Healing rate: 5.4 mm2/day. Healing time: 93 days. Wound size: 25 × 20 × 3 mm w/undermining. Age of wound when treatment started: 4 months. Subject: 68/female. Diabetes, peripheral neuropathy, and venous insufficiency. Necrotic tissue was treated with moistened MIRRAGEN™ advanced wound matrix for 2 days to soften and loosen necrotic tissue for easy ...
In April of this year, prior to the beginning of our International Conference in Toronto, I had the rare opportunity to meet for several hours with Tiina Karu, Mary Dyson, Shimon Rochkind, Chukuka Enwemeka and several other leading authorities involved in the field of laser technology. Whereas their interests encompass basic research, pathology, tissue response mechanisms and clinical ...
Patient History Patient is an 88-year-old female (post-BKA) who developed a large blister on the distal end of the stump within the first month post-op. It was treated with Kerlix and standard wound care at a LTCH. Three months later, the wound had a large area of eschar with purulent drainage. Patient taken to O/R for wound revision and primary closure with NPWT applied to the wound area. Wound ...
Patient History Patient is a 54-year-old male who underwent surgery to remove implanted hardware and osteophytes following a calcaneal fracture repair. Post-operatively, the surgical incision dehisced. The resulting wound was open for a period of 4 weeks and was refractory to standard of care, wet-to-dry dressings, and an Unna boot. Patient was offered the option to be referred to a plastic ...
Patient History Patient is a 35-year-old with obesity and venous insufficiency, status post-surgery for the repair of an ankle fracture. Surgical site dehisced and the patient was treated with Profore wraps, Unna boots, and standard wound care for two months. Primary Diagnosis Surgical dehiscence Treatment & Outcome Restrata was added to the treatment regimen and applied after wound ...
Patient History Patient is a 40-year-old female with a history of type 2 diabetes. Patient presented to the Emergency Room with a diabetic foot ulcer and infection. The surgeon took the patient to the OR for debridement, drained the infection, and started antibiotics. The patient was treated with advanced modalities that included NPWT and a bioengineered skin substitute. Primary Diagnosis ...
Patient: 48-Year-old male suffering from non-healing surgical wound Medical History: Diabetes, vascular issues, PVD, not a candidate for vascular interventions or HBO treatment Wound History: Patient initially had 2 blisters on great and second toe that lead to great toe amputation. Patient was scheduled for BKA, yet the wound showed enough improvement after one week of Continuous Diffusion of ...
Christine Salcher, DPM Sherman, Texas and Amyee McAlister, Healthline Patient: 50-year-old Caucasian female with a pressure ulcer that has progressively gotten larger, deeper, more malodorous, fibrotic, and necrotic Comorbidities: Diabetes, diabetic retinopathy & peripheral neuropathy Age of Wound: 90 days Days on Service: 55 days Outcome: Goals met. Wound healed. High patient ...
Treatment of pediatric soft tissue wounds presents additional complexities and highlights unique requirements. This piece provides a synopsis of an article [1] published in the Journal of Pediatric Surgery Case Reports by Dr. Kyle Crowley and his colleagues from the Division of Paediatric Surgery at Townsville University Hospital in Queensland, Australia. NovoSorb® BTM, a biodegradable ...
NovoSorb® BTM (Biodegradable Temporizing Matrix) is a biocompatible device designed to temporize dermal injuries where tissue has been decimated or lost and to facilitate dermal repair by providing temporary wound closure and a scaffold for the generation of new dermal tissue. NovoSorb BTM is intended for single application and shouldn’t be applied into overtly infected wounds. ...
Most superficial wounds (ones involving the epidermis and sometimes the partial dermis) heal quickly, often without scarring, and typically covered with readily available wound dressings. However, when trauma occurs and large portions of the epidermis and dermis are destroyed, it may be necessary to put a structure in place to aid the body in generating new tissue. NovoSorb® BTM is a fully ...
Whether you are a first-time user or an expert in NovoSorb BTM (Biodegradable Temporizing Matrix) for dermal repair and reconstruction, we’re here to answer questions you may have regarding its use in a clinical setting. Below is a list of questions we get asked the most regarding the use of NovoSorb BTM. 1. Can NovoSorb BTM Be Applied with a Graft in a One-Stage Procedure? NovoSorb BTM ...
The following case was performed at the Pacific Dental Convention’s Live Surgical Stage held March 8th, 2018 in Vancouver, BC. The patient is a healthy 58 year old male with no known allergies or medical contra-indications to dental treatment. Patient presented with a Class III malocclusion for which he received both orthodontic and oral surgery consultations; however, he was not ...
INTRODUCTION The replacement of a single central incisor may be one of the most demanding implant treatments clinicians face. Still, clinicians have been able to achieve aesthetic results in these challenging cases through excellent treatment planning and meticulous surgical placement. The following case study highlights how Dr. Zokol was able to integrate Inliant® into his treatment plan ...
INTRODUCTION The goal of the implant surgeon is to place the implant in the ideal position, to support the prosthesis for the best long term prognosis, while managing important anatomical landmarks. With the aid of Cone Beam CT scans the implant surgeon is able to evaluate, in three dimension, the ridge, important anatomy, as well as pre-plan implant placement in the most ideal position. ...